Nearly half of all women experience pain or physical limitations after breast cancer surgery. MSK physiatrist Michael Stubblefield answers questions about this condition, known as postmastectomy reconstruction syndrome.
New findings reveal a link between obesity and death from breast cancer. Memorial Sloan Kettering clinical nutritionist Cara Anselmo talks about the issue and offers tips on maintaining a healthy weight when coping with breast cancer.
The correct identification and naming of a tumor’s type is increasingly important in the era of personalized medicine, and tumors that exhibit features of more than one type can complicate that process.
Good Morning America reporter Amy Robach was diagnosed with breast cancer at age 40 after receiving her first mammogram. For Memorial Sloan Kettering experts, the message behind this story bears repeating: Mammograms save lives.
Misconceptions may be keeping many women from getting breast reconstruction after a mastectomy, even though the procedure can help improve quality of life for cancer survivors, according to a new review. MSK’s Monica Morrow and Babak J. Mehrara are mentioned.
Medical oncologist Clifford Hudis discussed new recommendations from the American Society of Clinical Oncology that suggest that breast cancer patients take the drug tamoxifen for 10 years after treatment instead of 5.
Breast cancer surgeon Tari King discussed a study that showed that most women who have a double mastectomy after a breast cancer diagnosis do so despite a very low risk of developing cancer in the healthy breast.
Breast Cancer Medicine Service Chief Clifford Hudis commented on research that suggests that women who eat a lot of fat, particularly saturated fat, may be at higher risk of certain types of breast cancer.
Diagnostic radiologist Carol Lee commented on a study that found that false-positive mammograms do increase anxiety, but the feeling is short-lived and most women go on to have breast screening in the future.
Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton commented on a study that found that a new type of drug reduced the risk that breast cancer would progress in women with advanced disease.
Medical oncologist Heather McArthur discussed why an individualized approach is important in treating cancer as well as her research in immunotherapy. Gynecologist Noah Kauff discussed the risks and recommendations for women with BRCA gene mutations.